The Health and Drug Alerts article on Zelnorm1 contained 2 errors. First, the complete description for Zelnorm is “the serotonin 5-HT4 receptor partial agonist, tegaserod (Zelnorm).” Second, the approximate number of people who will have very serious diarrhea is 1 in 2500 (or 0.04%), not 1 in 250 (or 0.4%) as stated in the article.
Reference
- 1.Wooltorton E. Tegaserod (Zelnorm) for irritable bowel syndrome: reports of serious diarrhea and intestinal ischemia. CMAJ 2004;170(13):1908. [DOI] [PMC free article] [PubMed]